How big is the Plasma Product Market | Size, Share & Future Opportunities 2025

How big is the plasma product market?

The market growth is driven by rising prevalence of chronic and rare diseases, increasing demand for immunoglobulins and clotting factors, and advancements in plasma fractionation technologies.

Key Growth Drivers of the Plasma Product Market

• Rising prevalence of immune deficiencies and bleeding disorders
• Growing use of immunoglobulins in autoimmune disease treatment
• Increasing demand for albumin in critical care and liver disease
• Expansion of plasma collection centres worldwide
• Supportive government initiatives and healthcare spending growth

Plasma Product Market Trends

The plasma product market is experiencing trends such as growing adoption of recombinant therapies alongside plasma-derived products, rising focus on plasma self-sufficiency in developing countries, and increased awareness of plasma donation. Companies are innovating in pathogen-reduction technologies, cold chain logistics, and product formulations. Strategic partnerships between plasma collection organizations and pharmaceutical firms are reshaping the supply chain.

Emerging Developments in the Plasma Product Market

The plasma product market is undergoing developments like expansion of plasma collection infrastructure, introduction of advanced fractionation facilities, and rising clinical trials for novel plasma-derived therapies. Companies are investing in improving donor recruitment, enhancing manufacturing efficiency, and integrating AI-driven inventory management. Mergers, acquisitions, and collaborations are strengthening global distribution and patient access.

List of Leading Companies in the Plasma Product Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. CSL Behring (CSL Limited)

CSL Behring is a global leader in plasma-derived therapies, producing immunoglobulins, clotting factors, and albumin for rare and serious disease treatments.

2. Grifols, S.A.

Grifols specializes in plasma collection and plasma-derived medicines, supporting therapies in immunology, hematology, neurology, and hospital pharmacy worldwide.

3. Takeda Pharmaceutical Company Limited

Takeda provides innovative plasma-derived therapies, focusing on hematology, immunology, and rare diseases through its global plasma unit.

4. Octapharma AG

Octapharma is one of the largest human protein product manufacturers, offering plasma-derived and recombinant products for hematology, immunotherapy, and critical care.

5. Kedrion Biopharma

Kedrion develops plasma-derived therapies for rare conditions, producing immunoglobulins and coagulation factors for global healthcare.

6. Biotest AG

Biotest focuses on plasma protein products for hematology, immunology, and intensive care, improving quality of life for patients worldwide.

7. ADMA Biologics, Inc.

ADMA Biologics manufactures plasma-derived biologics, targeting immunodeficiency, infectious diseases, and immune-related health conditions.

8. LFB S.A.

LFB develops plasma-derived medicines and recombinant proteins, serving immunology, hemostasis, and intensive care medicine.

9. China Biologic Products Holdings, Inc.

China Biologic Products is a leading plasma-based therapy provider, supplying immunoglobulins and coagulation factor treatments.

10. Sanquin

Sanquin is a not-for-profit organization managing blood supply and plasma-derived medicine production, supporting healthcare across Europe.

How big is the Plasma Product Market : FAQ's